Search company, investor...
Search

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

veraquel.com

Stage

Grant | Alive

Total Raised

$50K

Last Raised

$50K | 9 yrs ago

About Veraquel Technologies

Veraquel Technologies is transforming the purification of peptide drugs at discovery and large-scale manufacturing scales. Veraquel Technologies is commercializing a transformative platform technology for the synthesis and manufacturing of peptides, applicable from discovery to large-scale production. This patented technology has the potential to eliminate the need for labor-intensive column separations, revolutionizing the process of manufacturing scale-up and enabling the high-throughput parallel purification of peptides for library-based approaches to drug discovery.

Veraquel Technologies Headquarters Location

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

  • What is Veraquel Technologies's latest funding round?

    Veraquel Technologies's latest funding round is Grant.

  • How much did Veraquel Technologies raise?

    Veraquel Technologies raised a total of $50K.

  • Who are the investors of Veraquel Technologies?

    Investors of Veraquel Technologies include MassChallenge.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.